Abstract:Objective To investigate the safety and efficacy of organ preservation surgery or "watch and wait" strategy for rectal cancer patients who are evaluated as clinical complete response (cCR) or near-cCR following neoadjuvant chemoradiotherapy (nCRT).Method From March 2011 to June 2016,35 patients with mid-low rectal cancers who were diagnosed as cCR or near-cCR following nCRT underwent organ preservation surgery with local excision or surveillance following "watch and wait" strategy in the Peking University Cancer Hospital.All the patients received re-evaluation and re-staging 6-12 weeks after the completion of nCRT,according to Habr-Gama and MSKCC criteria for the diagnosis of cCR or near-cCR.The near-cCR patients who received local excision and were pathologically diagnosed as T0Nx were also regarded as cCR.The end-points of this study included organ-preservation rate (OPR),sphincter-preservation rate (SPR),non-re-growth disease-free survival (NR-DFS),stoma-free survival,cancer-specific survival (CSS) and overall survival (OS).Kaplan-Meier curve was used to estimate the survival data at 3 years.Results A total of 35 cases were analyzed including 24 males (68.6％) and 11 females (31.4％).The median age was 60 (range 37-79) years and the median distance from tumor to anal edge was 4 (2-8) cm.Thirty-three patients received 50.6 Gy/22f IMRT with capecitabine and two patients received 50 Gy/25f RT with capecitabine.The cCR and near-cCR rates were 74.3％(26/35) and 25.7％ (9/35) respectively.Excision biopsy was performed in 4 near-cCR cases to confirm the diagnosis of cCR.The non-re-growth DFS rate was 14.3％(5/35) and the median time of tumor re-growth was 6.7 (4.7-37.4) months.In five patients with tumor re-growth,four were salvaged by radical rectal resections and one received local excision.The distant metastasis rate was 5.7％ (2/35),one patient presented resectable liver metastasis and received radical resection,another patient presented multiple bone metastases and was still alive.The median follow-up time was 43.7 (6.1-71.4) months.At three years,the organ-preservation rate was 88.6％ (31/35),the sphincter-preservation rate was 97.1％ (34/35).No local recurrence was observed in five patients who received salvage surgery.The non-re-growth DFS was 94.0％.Three patients died of non-rectal cancer related events.The cancer-specific survival was 100％,the overall survival was 92.7％ and the stoma-free survival rate was 90.0％.Conclusions Organ preservation surgery or "watch and wait" strategy for cCR or near-cCR patients is feasible and achieves good outcomes.This strategy can be an alternative to standard care,improve patient's quality of life and facilitate tailored treatment for mid-low rectal cancer following nCRT,however,it should be cautiously applied in near-cCR patients before local excision biopsy.

Suitable T stage for cryosurgery to spare the anus in patients with low rectal cancer

CT guided cryoablation in local recurrence after radical resection of the rectal carcinoma

The Feasibility and Safety of Cryoablation As an Adjuvant Therapy with Transurethral Resection of Bladder Tumor: A Pilot Study.

Transanal Endoscopic Microsurgery Vs. Radical Surgery for Mid-Low Rectal Cancer in Patients with Clinical Complete or Near-Complete Response after Neoadjuvant Chemoradiotherapy.

Cryoablation for nonmetastatic castration resistant prostate cancer: feasibility, safety, quality of life and oncological outcomes

Transrectal ultrasound-guided transperineal cryosnrgical ablation for localized prostate cancer

Safety and Therapeutic Effects of Local Anesthetic Percutaneous Renal Cryoablation for T1 Renal Cell Carcinoma with High Surgical Risk

Image-guidedcryoablation in Unresectable or Recurrent Advanced Colorectal Cancer: a Retrospective Study

Ct-Guided Cryoablation For Unresectable Pelvic Recurrent Colorectal Cancer: A Retrospective Study

Cryosurgery as primary treatment for localized prostate cancer

Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center

Revolutionizing Sphincter Preservation in Ultra-Low Rectal Cancer: Exploring the Potential of Transanal Endoscopic Intersphincteric Resection (Tae-Isr): a Propensity Score-Matched Cohort Study.

Endoscopic balloon cryoablation plus transurethral resection for bladder cancer: A phase 2, multicenter, randomized, controlled trial

Long-term prognostic analysis on complete / near-complete clinical remission for mid-low rectal cancer after neoadjuvant chemoradiotherapy

Endoscopic Balloon Cryoablation Against Single Instillation after Transurethral Resection of Bladder Cancer: A Multicenter, Randomized, Controlled Noninferiority Trial.

Salvage Cryoablation for Recurrent Prostate Cancer Following Primary External Beam Radiotherapy or Primary Cryotherapy: a Propensity Score Matched Analysis of Mid-term Oncologic and Functional Outcomes

Laparoscopic intersphincteric resection with intraoperative radiotherapy using low-energy X-rays for locally advanced ultra-low rectal cancer

Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: A new era for anal preservation

A Retrospective Study on the Feasibility of Completely Laparoscopic Transabdominal Approach Partial Intersphincteric Resection.

[Evaluation of Preoperative Radiotherapy or Chemoradiotherapy in Sphincter Preservation for Locally Advanced Middle-Low Rectal Cancer].

Clinical efficacy and pathological outcomes of transanal endoscopic intersphincteric resection for low rectal cancer